ストックスクリーナーアプリを入手
7.60
1.20%
0.09
アフターアワーズ：
7.64
0.04
+0.53%
Eupraxia Pharmaceuticals Inc (EPRX) 最新ニュース
You need to know this Canadian biotech stock, analyst says - Cantech Letter
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Announces Earnings Results, Misses Estimates By $0.21 EPS - MarketBeat
Lifesci Capital Has Negative Outlook of EPRX FY2026 Earnings - MarketBeat
What is HC Wainwright's Estimate for EPRX Q1 Earnings? - MarketBeat
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Lowered by Zacks Research - MarketBeat
Profit Recap: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR2026 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Q2 Earnings Estimate for EPRX Issued By HC Wainwright - MarketBeat
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given New $11.00 Price Target at HC Wainwright - Defense World
EPRX stock on retail radar after strong remission data in digestive disease trial - MSN
Buyout Rumor: Whats BioXcel Therapeutics Incs historical return2026 Trade Ideas & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis - Investing News Network
H.C. Wainwright cuts Eupraxia Pharmaceuticals price target on higher costs - Investing.com
Eupraxia Pharmaceuticals Inc. - Baystreet.ca
HC Wainwright Has Lowered Expectations for Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Price - MarketBeat
EPRX Stock On Retail Radar After Strong Remission Data In Digestive Disease Trial - Asianet Newsable
A Little-Known Biotech Is Gaining Retail Buzz With Its Latest Trial Data - Stocktwits
Eupraxia Pharmaceuticals Posts Strong Six-Month EoE Data for EP-104GI as RESOLVE Trial Advances - TipRanks
New Eupraxia data: EoE patients keep symptom relief for 24 weeks - Stock Titan
Freedman lifts Eupraxia (EPRX) stake to 9% after 2026 share purchases - Stock Titan
Aug Reactions: Is Eupraxia Pharmaceuticals Inc affected by consumer sentiment2026 Reactions & Community Consensus Trade Signals - baoquankhu1.vn
Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Rises By 19.4% - MarketBeat
Ally Bridge Group NY LLC Buys New Shares in Eupraxia Pharmaceuticals Inc. $EPRX - MarketBeat
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
Cantor Fitzgerald Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX) - The Globe and Mail
Eupraxia Pharmaceuticals (NASDAQ: EPRX) files 2025 Form 40-F with audited statements - Stock Titan
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results - Sahm
Eupraxia Widens Q4 Loss but Extends Cash Runway With $63 Million Financing - TipRanks
Eupraxia testing EoE drug extends cash runway to 2028 - Stock Titan
How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily
(EPRX) Market Insights and Trading Signals (EPRX:CA) - Stock Traders Daily
Canadian Investment Regulatory Organization Trading HaltEPRX.WT - marketscreener.com
Eupraxia Pharmaceuticals stock rating reiterated at Raymond James By Investing.com - Investing.com Canada
(EPRX) Stock Analysis and Trading Signals (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Optimized Trading Opportunities - Stock Traders Daily
Eupraxia Pharmaceuticals Raises US$63.2 Million in February 2026 Equity Offering to Advance GI Pipeline - TipRanks
Eupraxia (EPRX) raises $63.2M to fund EP-104GI and GI pipeline - Stock Titan
Aug Patterns: Whats the beta of Eupraxia Pharmaceuticals Inc stockGDP Growth & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
(EPRX.WT.A) Trading Strategy and Analysis - Stock Traders Daily
Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering - Global Legal Chronicle
(EPRX.WT.A) Equity Market Report - Stock Traders Daily
(EPRX) Investment Performance Report (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Trading Report (EPRX.WT.A:CA) - Stock Traders Daily
(EPRX) Proactive Strategies (EPRX:CA) - Stock Traders Daily
Bloom Burton initiates Eupraxia stock with buy rating on EoE drug - Investing.com Nigeria
Bloom Burton initiates Eupraxia stock with buy rating on EoE drug By Investing.com - Investing.com Australia
(EPRX.WT.A) Technical Pivots with Risk Controls - Stock Traders Daily
EPRXEupraxia Pharmac Latest Stock News & Market Updates - Stock Titan
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Eupraxia Pharmaceuticals closes $63.2M public offering - Investing.com India
Eupraxia Pharmaceuticals closes $63.2M public offering By Investing.com - Investing.com Canada
Eupraxia Pharmaceuticals stock gains after $63M offering - Investing.com Nigeria
Eupraxia Pharmaceuticals stock gains after $63M offering By Investing.com - Investing.com Canada
Eupraxia Pharmaceuticals Raises US$63.2 Million to Advance GI Pipeline and Commercial Readiness - TipRanks
1.20%
0.06%
大文字化:
|
ボリューム (24 時間):